Diagnostic Medicine in Brazil Mapped Whitespaces Report¶
Potential Whitespaces¶
| Whitespace ID | Whitespace Description | Market Signals Identified | Potential Addressable Market (Annual, USD) |
|---|---|---|---|
| 1A | Decentralized POCT Networks for Underserved Populations | Demand: High patient demand for access/reduced wait times (SUS, remote areas); patient willingness for accessible points; SUS need to expand primary care capacity; increased health awareness. Offer: POCT tech advancements; ANVISA registrations for POCT; industry interest in decentralized models; digital health integration. |
$240 Million - $2.4 Billion |
| 1B & 8B | Integrated Telemedicine and Remote Diagnostics for Specialist Scarcity | Demand: Acute shortage of specialists (radiologists, pathologists) in remote areas; long wait times for interpretations; patient/GP demand for remote specialist access; hospital demand for complex exam support. Offer: Expansion of digital health/telemedicine; teleradiology/telepathology tech; emerging AI tools for remote review; specialist willingness for remote services. |
$2.16 Billion - $30 Billion |
| 2B | Affordable, Locally Manufactured Diagnostics for Basic Needs | Demand: SUS/payer pressure for cost reduction; high import dependency (price volatility); small/medium lab demand for affordable reagents/equipment; government interest in fostering national industry. Offer: Existing national manufacturers (Vyttra, Biocon); potential for local industry-research partnerships; growing GMP/ANVISA expertise; opportunity for high-volume, less complex test production. |
$424 Million - $848 Million |
| 3A & 7A | Specialized Hubs for Advanced Molecular & Genomic Testing with B2B Outreach | Demand: Growing demand for personalized medicine (oncology, rare diseases); physician demand for advanced molecular/genetic tests; patient interest in genetic screening; B2B demand from smaller labs/hospitals for complex testing. Offer: Tech advancements (NGS, PCR); decreasing sequencing costs; emergence of specialized genomic labs; large diagnostic networks expanding high-complexity offerings. |
$424 Million - $1.27 Billion (Future) |
| 4A | Interoperable Digital Platforms for Longitudinal Diagnostic Data Management | Demand: Patient desire for health record access; physician need for comprehensive data; health system recognition of inefficiencies from fragmented data; growing volume of diagnostic data. Offer: Cloud computing, data security, API tech advancements; government initiatives (RNDS); proliferation of EHR/LIS/RIS needing communication; startups/IT companies developing health data platforms. |
$10.4 Million - $157.5 Million |
| 5B | Patient-Centric Convenience Models (At-Home & Digital First) | Demand: Growing consumer expectations for convenience/digital interaction; desire to minimize travel/wait times; interest in proactive health management; demand from busy/mobility-impaired individuals. Offer: Emergence of at-home collection startups (e.g., Beep); maturation of digital platforms (scheduling, results); logistics improvements; user-friendly self-collection kits. |
$600 Million - $7.2 Billion |
| 8A | AI-Augmented Diagnostic Support Services for Resource Optimization | Demand: Shortage of specialized diagnostic professionals; need for improved efficiency/turnaround times; desire to enhance diagnostic accuracy; pressure to manage costs by optimizing specialist time. Offer: AI algorithm advancements for medical image/pathology analysis; increasing regulatory approvals for AI tools; investment by equipment manufacturers/tech companies in AI; growing evidence of AI potential. |
$15 Million - $175 Million |
References¶
- Afip: Afip lança unidade de negócios de medicina diagnóstica. https://www.afip.com.br/afip-lanca-unidade-de-negocios-de-medicina-diagnostica/
- Associação Brasileira de Medicina Diagnóstica (Abramed): Pesquisa revela que brasileiros realizaram 2,4 bilhões de exames de diagnóstico em 2023. https://abramed.org.br/pesquisa-revela-que-brasileiros-realizaram-24-bilhoes-de-exames-de-diagnostico-em-2023/
- Medicina SA: Mercado de dispositivos médicos e diagnóstico in-vitro cresceu 57,9%. https://medicinasa.com.br/mercado-dispositivos-medicos/
- ABIMED. (2024, July 30). Inteligência artificial contribui para a evolução da medicina diagnóstica. https://abimed.org.br/ia-contribui-evolucao-medicina-diagnostica/
- Mordor Intelligence: Tamanho do mercado de diagnóstico in vitro do Brasil e análise de ações – Tendências e previsões de crescimento (2024 - 2029). https://www.mordorintelligence.com/pt/industry-reports/brazil-in-vitro-diagnostics-market
- Vyttra Diagnósticos: soluções diagnósticas sem fronteiras. https://vyttra.com.br/
- Biocon Diagnósticos. https://biocon.com.br/
- Hospital Sírio-Libanês: Tendências da Saúde para 2025: novidades e o que deve vir. https://hospitalsiriolibanes.org.br/resources/publicacoes/tendencias-da-saude-para-2025-novidades-e-o-que-deve-vir
- Shift: Tendências na medicina diagnóstica para 2025: inovação, eficiência e foco no paciente. https://medical.shift.com.br/tendencias-medicina-diagnostica-2025/
- Interfarma: Medicina diagnóstica tem papel decisivo na saúde suplementar. https://interfarma.org.br/noticias/medicina-diagnostica-tem-papel-decisivo-na-saude-suplementar